1. Home
  2. AWRE vs SLGL Comparison

AWRE vs SLGL Comparison

Compare AWRE & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWRE
  • SLGL
  • Stock Information
  • Founded
  • AWRE 1986
  • SLGL 1997
  • Country
  • AWRE United States
  • SLGL Israel
  • Employees
  • AWRE N/A
  • SLGL N/A
  • Industry
  • AWRE Computer Software: Prepackaged Software
  • SLGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • AWRE Technology
  • SLGL Health Care
  • Exchange
  • AWRE Nasdaq
  • SLGL Nasdaq
  • Market Cap
  • AWRE 50.3M
  • SLGL 69.1M
  • IPO Year
  • AWRE 1996
  • SLGL 2018
  • Fundamental
  • Price
  • AWRE $2.71
  • SLGL $24.35
  • Analyst Decision
  • AWRE
  • SLGL
  • Analyst Count
  • AWRE 0
  • SLGL 0
  • Target Price
  • AWRE N/A
  • SLGL N/A
  • AVG Volume (30 Days)
  • AWRE 49.9K
  • SLGL 32.4K
  • Earning Date
  • AWRE 10-29-2025
  • SLGL 11-14-2025
  • Dividend Yield
  • AWRE N/A
  • SLGL N/A
  • EPS Growth
  • AWRE N/A
  • SLGL N/A
  • EPS
  • AWRE N/A
  • SLGL N/A
  • Revenue
  • AWRE $16,146,999.00
  • SLGL $23,931,000.00
  • Revenue This Year
  • AWRE N/A
  • SLGL N/A
  • Revenue Next Year
  • AWRE N/A
  • SLGL $31.17
  • P/E Ratio
  • AWRE N/A
  • SLGL N/A
  • Revenue Growth
  • AWRE N/A
  • SLGL 264.86
  • 52 Week Low
  • AWRE $1.35
  • SLGL $4.01
  • 52 Week High
  • AWRE $2.95
  • SLGL $30.00
  • Technical
  • Relative Strength Index (RSI)
  • AWRE 58.28
  • SLGL 59.60
  • Support Level
  • AWRE $2.71
  • SLGL $23.13
  • Resistance Level
  • AWRE $2.95
  • SLGL $24.85
  • Average True Range (ATR)
  • AWRE 0.18
  • SLGL 2.20
  • MACD
  • AWRE 0.04
  • SLGL -0.53
  • Stochastic Oscillator
  • AWRE 71.76
  • SLGL 37.22

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Share on Social Networks: